List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Oncology Biomarker Market Size Analysis from 2022 to 2027
1.5.1 Global Oncology Biomarker Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Oncology Biomarker Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Oncology Biomarker Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Oncology Biomarker Industry Impact
Chapter 2 Global Oncology Biomarker Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oncology Biomarker (Volume and Value) by Type
2.1.1 Global Oncology Biomarker Consumption and Market Share by Type (2016-2021)
2.1.2 Global Oncology Biomarker Revenue and Market Share by Type (2016-2021)
2.2 Global Oncology Biomarker (Volume and Value) by Application
2.2.1 Global Oncology Biomarker Consumption and Market Share by Application (2016-2021)
2.2.2 Global Oncology Biomarker Revenue and Market Share by Application (2016-2021)
2.3 Global Oncology Biomarker (Volume and Value) by Regions
2.3.1 Global Oncology Biomarker Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Oncology Biomarker Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Oncology Biomarker Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Oncology Biomarker Consumption by Regions (2016-2021)
4.2 North America Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
4.10 South America Oncology Biomarker Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Oncology Biomarker Market Analysis
5.1 North America Oncology Biomarker Consumption and Value Analysis
5.1.1 North America Oncology Biomarker Market Under COVID-19
5.2 North America Oncology Biomarker Consumption Volume by Types
5.3 North America Oncology Biomarker Consumption Structure by Application
5.4 North America Oncology Biomarker Consumption by Top Countries
5.4.1 United States Oncology Biomarker Consumption Volume from 2016 to 2021
5.4.2 Canada Oncology Biomarker Consumption Volume from 2016 to 2021
5.4.3 Mexico Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 6 East Asia Oncology Biomarker Market Analysis
6.1 East Asia Oncology Biomarker Consumption and Value Analysis
6.1.1 East Asia Oncology Biomarker Market Under COVID-19
6.2 East Asia Oncology Biomarker Consumption Volume by Types
6.3 East Asia Oncology Biomarker Consumption Structure by Application
6.4 East Asia Oncology Biomarker Consumption by Top Countries
6.4.1 China Oncology Biomarker Consumption Volume from 2016 to 2021
6.4.2 Japan Oncology Biomarker Consumption Volume from 2016 to 2021
6.4.3 South Korea Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 7 Europe Oncology Biomarker Market Analysis
7.1 Europe Oncology Biomarker Consumption and Value Analysis
7.1.1 Europe Oncology Biomarker Market Under COVID-19
7.2 Europe Oncology Biomarker Consumption Volume by Types
7.3 Europe Oncology Biomarker Consumption Structure by Application
7.4 Europe Oncology Biomarker Consumption by Top Countries
7.4.1 Germany Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.2 UK Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.3 France Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.4 Italy Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.5 Russia Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.6 Spain Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.7 Netherlands Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.8 Switzerland Oncology Biomarker Consumption Volume from 2016 to 2021
7.4.9 Poland Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 8 South Asia Oncology Biomarker Market Analysis
8.1 South Asia Oncology Biomarker Consumption and Value Analysis
8.1.1 South Asia Oncology Biomarker Market Under COVID-19
8.2 South Asia Oncology Biomarker Consumption Volume by Types
8.3 South Asia Oncology Biomarker Consumption Structure by Application
8.4 South Asia Oncology Biomarker Consumption by Top Countries
8.4.1 India Oncology Biomarker Consumption Volume from 2016 to 2021
8.4.2 Pakistan Oncology Biomarker Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Oncology Biomarker Market Analysis
9.1 Southeast Asia Oncology Biomarker Consumption and Value Analysis
9.1.1 Southeast Asia Oncology Biomarker Market Under COVID-19
9.2 Southeast Asia Oncology Biomarker Consumption Volume by Types
9.3 Southeast Asia Oncology Biomarker Consumption Structure by Application
9.4 Southeast Asia Oncology Biomarker Consumption by Top Countries
9.4.1 Indonesia Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.2 Thailand Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.3 Singapore Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.4 Malaysia Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.5 Philippines Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.6 Vietnam Oncology Biomarker Consumption Volume from 2016 to 2021
9.4.7 Myanmar Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 10 Middle East Oncology Biomarker Market Analysis
10.1 Middle East Oncology Biomarker Consumption and Value Analysis
10.1.1 Middle East Oncology Biomarker Market Under COVID-19
10.2 Middle East Oncology Biomarker Consumption Volume by Types
10.3 Middle East Oncology Biomarker Consumption Structure by Application
10.4 Middle East Oncology Biomarker Consumption by Top Countries
10.4.1 Turkey Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.3 Iran Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.5 Israel Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.6 Iraq Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.7 Qatar Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.8 Kuwait Oncology Biomarker Consumption Volume from 2016 to 2021
10.4.9 Oman Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 11 Africa Oncology Biomarker Market Analysis
11.1 Africa Oncology Biomarker Consumption and Value Analysis
11.1.1 Africa Oncology Biomarker Market Under COVID-19
11.2 Africa Oncology Biomarker Consumption Volume by Types
11.3 Africa Oncology Biomarker Consumption Structure by Application
11.4 Africa Oncology Biomarker Consumption by Top Countries
11.4.1 Nigeria Oncology Biomarker Consumption Volume from 2016 to 2021
11.4.2 South Africa Oncology Biomarker Consumption Volume from 2016 to 2021
11.4.3 Egypt Oncology Biomarker Consumption Volume from 2016 to 2021
11.4.4 Algeria Oncology Biomarker Consumption Volume from 2016 to 2021
11.4.5 Morocco Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 12 Oceania Oncology Biomarker Market Analysis
12.1 Oceania Oncology Biomarker Consumption and Value Analysis
12.2 Oceania Oncology Biomarker Consumption Volume by Types
12.3 Oceania Oncology Biomarker Consumption Structure by Application
12.4 Oceania Oncology Biomarker Consumption by Top Countries
12.4.1 Australia Oncology Biomarker Consumption Volume from 2016 to 2021
12.4.2 New Zealand Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 13 South America Oncology Biomarker Market Analysis
13.1 South America Oncology Biomarker Consumption and Value Analysis
13.1.1 South America Oncology Biomarker Market Under COVID-19
13.2 South America Oncology Biomarker Consumption Volume by Types
13.3 South America Oncology Biomarker Consumption Structure by Application
13.4 South America Oncology Biomarker Consumption Volume by Major Countries
13.4.1 Brazil Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.2 Argentina Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.3 Columbia Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.4 Chile Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.5 Venezuela Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.6 Peru Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Oncology Biomarker Consumption Volume from 2016 to 2021
13.4.8 Ecuador Oncology Biomarker Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Oncology Biomarker Business
14.1 Novartis AG
14.1.1 Novartis AG Company Profile
14.1.2 Novartis AG Oncology Biomarker Product Specification
14.1.3 Novartis AG Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Merck & Co.
14.2.1 Merck & Co. Company Profile
14.2.2 Merck & Co. Oncology Biomarker Product Specification
14.2.3 Merck & Co. Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 F.Hoffmann-La Roche Ltd.
14.3.1 F.Hoffmann-La Roche Ltd. Company Profile
14.3.2 F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Specification
14.3.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Bristol-Myers Squibb
14.4.1 Bristol-Myers Squibb Company Profile
14.4.2 Bristol-Myers Squibb Oncology Biomarker Product Specification
14.4.3 Bristol-Myers Squibb Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Abbott Laboratories
14.5.1 Abbott Laboratories Company Profile
14.5.2 Abbott Laboratories Oncology Biomarker Product Specification
14.5.3 Abbott Laboratories Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Eli Lilly and Company
14.6.1 Eli Lilly and Company Company Profile
14.6.2 Eli Lilly and Company Oncology Biomarker Product Specification
14.6.3 Eli Lilly and Company Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Qiagen N.V.
14.7.1 Qiagen N.V. Company Profile
14.7.2 Qiagen N.V. Oncology Biomarker Product Specification
14.7.3 Qiagen N.V. Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 GlaxoSmithKline plc
14.8.1 GlaxoSmithKline plc Company Profile
14.8.2 GlaxoSmithKline plc Oncology Biomarker Product Specification
14.8.3 GlaxoSmithKline plc Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Genomic Health
14.9.1 Genomic Health Company Profile
14.9.2 Genomic Health Oncology Biomarker Product Specification
14.9.3 Genomic Health Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Pfizer
14.10.1 Pfizer Company Profile
14.10.2 Pfizer Oncology Biomarker Product Specification
14.10.3 Pfizer Oncology Biomarker Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Oncology Biomarker Market Forecast (2022-2027)
15.1 Global Oncology Biomarker Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Oncology Biomarker Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Oncology Biomarker Value and Growth Rate Forecast (2022-2027)
15.2 Global Oncology Biomarker Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Oncology Biomarker Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Oncology Biomarker Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Oncology Biomarker Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Oncology Biomarker Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Oncology Biomarker Consumption Forecast by Type (2022-2027)
15.3.2 Global Oncology Biomarker Revenue Forecast by Type (2022-2027)
15.3.3 Global Oncology Biomarker Price Forecast by Type (2022-2027)
15.4 Global Oncology Biomarker Consumption Volume Forecast by Application (2022-2027)
15.5 Oncology Biomarker Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
